Healthcare -
Biotechnology - NASDAQ - US
$ 0.356
-49.1 %
$ 129 M
Market Cap
-0.48
P/E
LXRX - LONG-TERM DEBT
Long-term Debt LXRX - Lexicon Pharmaceuticals, Inc.
105 M
LAST VALUE
838.32%
2 YEAR CAGR
-15.55%
5 YEAR CAGR
17.91%
10 YEAR CAGR